On July 2nd, the Taiyuan headquarters of Enhe Pharmaceutical welcomed a group of special "family members" - sales managers from all over the country, who got a close-up look at the profound heritage of this animal health enterprise that has been rooted in the land of Shanxi for nearly two decades.             Chairman Xin Lihai stated that under the multiple pressures of losses in the breeding sector and stricter industry regulation, "Liangdan" exceeded 500 cases per month, "Sikang" exceeded 300 cases per month, and "Wuwei Jiweikang" exceeded 20 tons per month... Senior veterinarian Teacher Zuo Zhenhuan, focusing on core products such as Hua Nang Jian, En Gu Yuan, Wu Wei Ji Wei SAN, Liang Dan, Jin Zun, Si Kang, and Gan Qing, started from the fundamental logic of relieving immunosuppression and deeply analyzed the precise application plans of each product in different epidemic scenarios.

    Technical Director Meng Qinghai focused on the current industry pain point of high incidence of immunosuppressive diseases in poultry, and dissected one by one the "2 1" high-yield and stable production plan of Dingkun Liquid, the core mechanism of immune regulation of Kairuide, and the system plan of Liangdan to relieve the immunosuppression of the reproductive system

    Dr. Zhang Kai, the leading doctor of Shanxi Langxin Doctor Innovation Station (Shanxi Agricultural University), started from the deep relationship between trace elements and the nutrition of laying hens, revealing the significant effects of eggshell Superior in improving eggshell strength, enhancing eggshell color, and reducing the rate of broken eggs. He proved the product value with solid figures at the end of the meeting. General Manager Xin focused on elaborating on the common diseases of poultry and waterfowl and the systematic solutions for improving production performance. He required all personnel to deeply understand the product mechanism, implement the work tone of "adhering to compliance, providing meticulous services, strengthening products, and keeping the original aspiration" for the second half of the year, and truly provide practical and effective precise solutions for the breeding end.

    In the future, Enhe Pharmaceutical will continue to uphold the concept of "The integrity of Shanxi merchants and the inheritance of good prescriptions", driven by technological innovation and adhering to the bottom line of compliant operation. We will join hands with our partners to jointly write a new chapter of high-quality development in the breeding industry.